In this study, we found that expression levels of OLFML2B increased with increased stage and grade, suggesting that OLFML2B promotes the progression of bladder cancer and increases the risk of invasion and deterioration of bladder cancer. The gene discussed is OLFML2B; the disease is urinary bladder carcinoma.